Skip to main content
OpenTrials

Clinical trial condition

Stomach Neoplasms

Explore clinical trials studying Stomach Neoplasms. Study availability and eligibility vary by location and protocol.

1,996 public trials 495 recruiting studies
Refine in advanced search Browse all conditions

Stomach Neoplasms trial results

Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

NCT05523947

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +12 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States
  • Southern Oncology Clinical Research Unit Adelaide, Australia
  • Austin Health Melbourne, Australia
View all 19 locations
View Trial Details
Recruiting

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

NCT07702292

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo, Lombardy, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Lombardy, Italy
  • Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore Roma, Italy
  • IRCCS Ospedale San Raffaele Milan, Segrate, Italy
View Trial Details
Recruiting

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

NCT06657144

Conditions
Adenocarcinoma Of Esophagus, Advanced Solid Tumor, Carcinoma, +26 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of Colorado - Aurora Cancer Center Aurora, Colorado, United States
  • Winship Cancer Center - Emory University Atlanta, Georgia, United States
View all 30 locations
View Trial Details
Recruiting

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

NCT04379596

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +13 more
Locations
  • Research Site Santa Monica, California, United States
  • Research Site Westwood, Kansas, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Boston, Massachusetts, United States
View all 100 locations
View Trial Details
Recruiting

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT06695845

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +64 more
Locations
  • Arizona Oncology Associates, PC - NAHOA Prescott, Arizona, United States
  • Rocky Mountain Cancer Center Littleton, Colorado, United States
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
View all 28 locations
View Trial Details
Recruiting

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

NCT07069712

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastroesophageal Adenocarcinoma, +6 more
Locations
  • Research Site Newark, Delaware, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Fairway, Kansas, United States
  • Research Site North Shores, Michigan, United States
View all 70 locations
View Trial Details

Related conditions